Olympus Introduces World's Only Forward-Viewing Curvilinear Ultrasound Gastrovideoscope

    Olympus Introduces World's Only Forward-Viewing Curvilinear Ultrasound
                               Gastrovideoscope

TGF-UC180J Provides the Potential for New Opportunities in EUS-Guided
Treatment of Diseases in the GI Tract

PR Newswire

CENTER VALLEY, Pa., Oct. 9, 2013

CENTER VALLEY, Pa., Oct. 9, 2013 /PRNewswire/ -- Olympus, a precision
technology leader in designing and delivering innovative solutions in the
medical and surgical field, among other core businesses, announced today the
launch of its 510(k) cleared and world's only forward-viewing curvilinear
ultrasound gastrovideoscope.

(Photo: http://photos.prnewswire.com/prnh/20131009/PH94030)

The advanced design of Olympus' new EUS scope with forward-viewing optics
makes it an ideal interventional tool. The design of the scope is significant
because it provides a reduced distal tip length compared to its
oblique-viewing counterparts. The combination of a shorter tip with wider
angulation capabilities (180 degrees up) delivers enhanced maneuverability and
handling. In addition, the scope's straight channel enables therapeutic
devices to be delivered directly (or head on) to the target site, potentially
providing easier access to regions of interest.

The scope's enhanced maneuverability and handling offers the potential to
improve visualization of fundus diseases, which can be challenging to view and
diagnose. In addition, an auxiliary water jet potentially provides better
acoustic coupling as well as savings in accessory costs by eliminating the
need for a balloon.

"The forward-viewing therapeutic echoendoscope is a major advance for
interventional endoscopy," said Dr. Kenneth Binmoeller, Medical Director of
the Interventional Endoscopy Service (IES) at California Pacific Medical
Center. "It is the first true 'hybrid' ultrasound endoscope, enabling both
ultrasound and endoscopy-guided interventions with the same instrument. This
will facilitate existing EUS-guided therapies, such as pseudocyst drainage, as
well as enable new EUS-guided treatments."

The TGF-UC180J is powered by the new, next-generation ProSound F75 Ultrasound
Imaging Platform, developed in partnership by Hitachi Aloka Medical, Ltd.,
which aids in more accurate diagnosis of diseases and cancers of the GI track
and surrounding organs. The scope is also backward compatible with prior
generation processors, including the Olympus EU-ME1 and Hitachi Aloka
SSD-α10.

"We are pleased to introduce this newest advance in EUS technology," said Luke
Calcraft, President of the Medical Systems Group at Olympus Corporation of the
Americas. "The TGF-UC180J has the potential to pave the way for new EUS-guided
treatments and assist healthcare facilities in their efforts to meet the
triple aim of Affordable Care through advanced diagnostic and therapeutic
capabilities, clinical and cost efficiencies, and less invasive interventions
for treatment of diseases and cancers in the GI tract."

Olympus is a pioneer of endoscopic ultrasound (EUS), which combines ultrasound
technology with endoscopy to better visualize the tissues of the digestive
tract and adjacent anatomical structures inside the human body. Conventional
ultrasound is performed by placing a transducer against the skin to produce
images of internal organs. With EUS, the transducer is endoscopically
inserted into the body via the digestive tract, putting it closer to the
region of interest to obtain higher resolution images.

The demand for minimally invasive procedures continues to grow with the
introduction of more advanced technologies. Over 250,000 EUS outpatient
procedures were performed in the United States in 2011 (Truven Health[i]) with
a 6% compound annual growth rate for the next 5 years (The Advisory Board
Company).

The advanced design of the TGF-UC180J scope can help healthcare providers
address the key requirements of healthcare reform, including:

  oIncreased Quality of Care – EUS drives optimal patient outcomes through
    easy identification and more accurate staging of diseases and cancers in
    the GI tract.
  oDecreased Costs – Interventional procedures can be performed in the GI
    suite which saves OR time. In addition, the forward-viewing scope does not
    require a balloon, reducing accessory expenditures.
  oEnhanced Patient Satisfaction – EUS offers patients a less invasive
    treatment compared to surgical interventions, and procedure times may be
    shorter.

The TGF-UC180J ultrasound gastrovideoscope will be showcased on October 13-15,
2013, at the ACG 2013 Annual Scientific Meeting, which will be held in San
Diego, CA. Physicians are invited to visit booth #1027 to further explore the
benefits of the new forward-viewing scope technology.

For more information or to evaluate the TGF-UC180J ultrasound
gastrovideoscope, please contact your Olympus representative or call
800-848-9024.

About Olympus Medical Systems Group

Olympus Medical Systems Group, a division of global technology leader Olympus,
develops solutions for healthcare professionals that help improve clinical
outcomes, reduce overall costs and enhance quality of life for their patients.
By enabling less invasive procedures, innovative diagnostic and therapeutic
endoscopy, Olympus is transforming the future of healthcare.

For more information, visit Olympus at www.medical.olympusamerica.com.

[i] Data for use in this study were supplied by Truven Health Analytics Inc.,
Ann Arbor, Michigan ("Truven Health"). Any analysis, interpretation or
conclusion based on these data is solely that of the authors and Truven Health
disclaims responsibility for any such analysis, interpretation or conclusion.

SOURCE Olympus Medical Systems Group

Website: http://www.medical.olympusamerica.com
Contact: Michael Levey, Olympus Corporation of the Americas, 484-896-5120,
michael.levey@olympus.com
 
Press spacebar to pause and continue. Press esc to stop.